Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias. [electronic resource]
Producer: 20150930Description: E149-51 p. digitalISSN:- 1096-8652
- Anemia, Hemolytic, Autoimmune -- blood
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Erythrocytes -- drug effects
- Hemolysis
- Humans
- Immunologic Factors -- therapeutic use
- Lenalidomide
- Plasma Exchange
- Rituximab
- Severity of Illness Index
- Splenectomy
- Steroids -- therapeutic use
- Thalidomide -- analogs & derivatives
- Time-to-Treatment
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.